Certara (NASDAQ:CERT) Announces FY 2026 Earnings Guidance

Certara (NASDAQ:CERT) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.310-0.340 for the period, compared to the consensus EPS estimate of 0.310. The company issued revenue guidance of $427.2 million-$431.4 million, compared to the consensus revenue estimate of $380.9 million.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. TD Cowen upped their price target on shares of Certara from $9.00 to $11.00 and gave the stock a “buy” rating in a research report on Tuesday, October 13th. Barclays lifted their price objective on shares of Certara from $7.50 to $9.00 and gave the company an “equal weight” rating in a report on Wednesday, October 7th. UBS Group lowered shares of Certara from a “buy” rating to a “neutral” rating and set a $10.00 price objective on the stock. in a report on Wednesday, September 30th. Weiss Ratings downgraded shares of Certara from a “sell (d)” rating to a “sell (d-)” rating in a research note on Thursday, October 8th. Finally, KeyCorp upped their target price on Certara from $9.00 to $12.00 and gave the stock an “overweight” rating in a report on Friday, October 16th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Certara presently has an average rating of “Hold” and an average target price of $9.18.

Certara Stock Up 9.8%

Shares of NASDAQ:CERT traded up $1.09 during trading on Thursday, reaching $12.18. The stock had a trading volume of 3,731,632 shares, compared to its average volume of 3,405,488. Certara has a one year low of $4.45 and a one year high of $12.25. The company has a market capitalization of $1.86 billion, a P/E ratio of -27.07 and a beta of 1.30. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 0.30. The firm’s 50-day simple moving average is $9.18 and its 200 day simple moving average is $7.32.

Certara (NASDAQ:CERT) last announced its earnings results on Thursday, November 5th. The company reported $0.09 earnings per share for the quarter, meeting the consensus estimate of $0.09. Certara had a negative net margin of 16.75% and a positive return on equity of 3.86%. The company had revenue of $94.90 million during the quarter, compared to the consensus estimate of $92.01 million. During the same period last year, the firm earned $0.14 earnings per share. Certara’s revenue was down 9.3% compared to the same quarter last year. Certara has set its FY 2026 guidance at 0.310-0.340 EPS. As a group, research analysts expect that Certara will post 0.21 EPS for the current fiscal year.

Certara Company Profile

Certara is a global provider of software and services that support drug development and regulatory approval. The company helps biopharmaceutical and pharmaceutical organizations use quantitative methods, modeling and simulation, and regulatory science to improve decisions throughout the development process.

Its software portfolio includes platforms for pharmacometric modeling and simulation, clinical trial design and analysis, pharmacology and safety assessment, data visualization, and regulatory submission management.